Ischemia and no obstructive coronary artery disease (INOCA) develo** evidence-based therapies and research agenda for the next decade
The Cardiovascular Disease in Women Committee of the American College of Cardiology,
in conjunction with interested parties (from the National Heart, Lung, and Blood Institute …
in conjunction with interested parties (from the National Heart, Lung, and Blood Institute …
Coronary microvascular dysfunction: an update
Many patients undergoing coronary angiography because of chest pain syndromes,
believed to be indicative of obstructive atherosclerosis of the epicardial coronary arteries …
believed to be indicative of obstructive atherosclerosis of the epicardial coronary arteries …
Reappraisal of ischemic heart disease: fundamental role of coronary microvascular dysfunction in the pathogenesis of angina pectoris
In recent years, it has become apparent that coronary microvascular dysfunction plays a
pivotal pathogenic role in angina pectoris. Functional and structural mechanisms can affect …
pivotal pathogenic role in angina pectoris. Functional and structural mechanisms can affect …
Treatment of coronary microvascular dysfunction
CN Bairey Merz, CJ Pepine… - Cardiovascular …, 2020 - academic.oup.com
Contemporary data indicate that patients with signs and symptoms of ischaemia and non-
obstructive coronary artery disease (INOCA) often have coronary microvascular dysfunction …
obstructive coronary artery disease (INOCA) often have coronary microvascular dysfunction …
Coronary microvascular dysfunction, microvascular angina, and treatment strategies
MA Marinescu, AI Löffler, M Ouellette, L Smith… - JACC: Cardiovascular …, 2015 - jacc.org
Angina without coronary artery disease (CAD) has substantial morbidity and is present in
10% to 30% of patients undergoing angiography. Coronary microvascular dysfunction …
10% to 30% of patients undergoing angiography. Coronary microvascular dysfunction …
[HTML][HTML] A'diamond'approach to personalized treatment of angina
In clinical guidelines, drugs for symptomatic angina are classified as being first choice (β-
blockers, calcium-channel blockers, short-acting nitrates) or second choice (ivabradine …
blockers, calcium-channel blockers, short-acting nitrates) or second choice (ivabradine …
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial …
Aims The mechanistic basis of the symptoms and signs of myocardial ischaemia in patients
without obstructive coronary artery disease (CAD) and evidence of coronary microvascular …
without obstructive coronary artery disease (CAD) and evidence of coronary microvascular …
Management of ischaemia with non-obstructive coronary arteries (INOCA)
Up to half of patients undergoing elective coronary angiography for the investigation of chest
pain do not present with evidence of obstructive coronary artery disease. These patients are …
pain do not present with evidence of obstructive coronary artery disease. These patients are …
Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association
JH Mieres, M Gulati, N Bairey Merz, DS Berman… - Circulation, 2014 - Am Heart Assoc
Historically, the focus of the diagnostic evaluation for symptomatic women and men has
been the detection of an obstructive coronary stenosis requiring revascularization (as …
been the detection of an obstructive coronary stenosis requiring revascularization (as …
Comprehensive Management of ANOCA, Part 2—Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review
Centers specializing in coronary function testing are critical to ensure a systematic approach
to the diagnosis and treatment of angina with nonobstructive coronary arteries (ANOCA) …
to the diagnosis and treatment of angina with nonobstructive coronary arteries (ANOCA) …